Table 2.
Infectious features of the reported patients with IgA-IRGN or SAGN.
| IgA-IRGN n = 336 |
SAGN n = 218 |
|||
|---|---|---|---|---|
| Causative bacteria | ||||
| Staphylococcal strain: | 58.4% | 185/317 | 100.0% | 218/218 |
| S. aureus | 54.9% | 174/305 | 81.7% | 178/218 |
| S. epidermidis | 1.7% | 5/298 | 6.9% | 15/218 |
| Other Staphylococcus | 1.7% | 5/298 | 11.5% | 25/218 |
| Streptococcus strain | 5.5% | 17/310 | 0.5% | 1/211 |
| Other bacteria | 21.0% | 65/310 | 3.3% | 7/211 |
| Unknown/not detected | 23.6% | 73/310 | 0% | 0/211 |
| Infection site: | ||||
| Cellulitis/skin infection | 25.1% | 68/271 | 23.6% | 45/191 |
| Endocarditis | 4.1% | 11/271 | 12.6% | 24/191 |
| Osteomyelitis/joint infection | 11.4% | 31/271 | 17.3% | 33/191 |
| Respiratory infection | 18.8% | 51/271 | 12.0% | 23/191 |
| Visceral abscess | 9.2% | 25/271 | 15.7% | 30/191 |
| Others | 22.9% | 62/271 | 19.4% | 37/191 |
| Unknown | 17.0% | 46/271 | 0% | 0/271 |